Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd.

Bullboard Posts

Post by larooon Aug 04, 2017 6:14pm

126 Views

Post# 26549919

Dead

This play is dead.
Cut my losses and moved $ into a pharma co. that's actually doing
something and on the verge of a massive break out.

RVV claim to fame was the Inmed term sheet which got the sp up into
the 40s. Never could close that deal or anything else for that matter.

Bullboard Posts

This junior mining stock offers billions in market exposure